Predict your next investment

Angel Investor (Group)
angelinvestorforum.com

See what CB Insights has to offer

Investments

70

Portfolio Exits

8

About Angel Investor Forum

The Angel Investor Forum provides accredited investors with the chance to pool their resources to fund seed-stage opportunities ($100K-$2M) with a particular focus in Connecticut and the Northeast area.

Angel Investor Forum Headquarter Location

222 Pitkin Street Suite 113

East Hartford, Connecticut, 06108,

United States

860.289.0878 x337

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Angel Investor Forum News

Founder Update: BIOARRAY Secures Series A Funding

Sep 26, 2017

We are excited to announce that VDC Founder company, BIOARRAY Therapeutics Inc., has gained $600,000 of new funding in the initial closing of the company’s Series A funding. The financing, led by Connecticut Innovations, included participation by the Angel Investor Forum, and Boston Harbor Angels, with additional participation from the City of New Haven/CURE Bioscience grant. BIOARRAY Therapeutics Inc. is a clinical-stage molecular diagnostics company developing and commercializing RNA-based predictive diagnostics for cancer. The new funding comes shortly after election of experienced life-science angel investor, Henry Kay, to BIOARRAY’s Board of Directors last Fall. To learn more about BIOARRY, click here Submit a Comment

Angel Investor Forum Investments

70 Investments

Angel Investor Forum has made 70 investments. Their latest investment was in GlucoGear as part of their Seed on October 10, 2018.

CBI Logo

Angel Investor Forum Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/10/2018

Seed

GlucoGear

$0.25M

Yes

6/29/2017

Seed VC

Lynq

$1.9M

Yes

1

7/16/2015

Unattributed

Delmarva Bancshares

$14M

Yes

1

4/29/2015

Series A

Subscribe to see more

$99M

Subscribe to see more

10

2/9/2015

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/10/2018

6/29/2017

7/16/2015

4/29/2015

2/9/2015

Round

Seed

Seed VC

Unattributed

Series A

Seed VC

Company

GlucoGear

Lynq

Delmarva Bancshares

Subscribe to see more

Subscribe to see more

Amount

$0.25M

$1.9M

$14M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

10

10

Angel Investor Forum Portfolio Exits

8 Portfolio Exits

Angel Investor Forum has 8 portfolio exits. Their latest portfolio exit was Delmarva Bancshares on October 31, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/31/2020

Acq - P2P

5

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

10/31/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Exit

Acq - P2P

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

5

10

10

10

10

Angel Investor Forum Team

2 Team Members

Angel Investor Forum has 2 team members, including current President, Edward Goodwin Ph D.

Name

Work History

Title

Status

Edward Goodwin Ph D

President

Current

Elizabeth Karter

President

Current

Name

Edward Goodwin Ph D

Elizabeth Karter

Work History

Title

President

President

Status

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.